Stockreport

Fungal Keratitis Treatment Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Merck & Co, Bausch Health, Gilead Biosciences, Pfizer, and Glenmark Pharma...

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF The global fungal keratitis treatment market is expected to reach an estimated $589.6 million by 2030 with a CAGR of 5.7% from 2024 to 2030. The future of the global [Read more]